Study Finds Neck Pain Is Symptom of Migraine—Not a Trigger of the Migraine
Neck pain associated with migraine cannot be attributed to increased trapezius activity during rest, mental stress, and physical activity or prolonged muscle activity and should be seen as an accompanying symptom of migraine.
Study: Mining Industry Noncompliance With Requirements Linked to Lung Disease Prevalence
Mines that are in compliance with the Mine Safety and Health Administration's requirements experience significantly lower lung disease cases over time compared with mines not in compliance. However, the lung disease burden among the coal mining industry has increased in the last decade.
The Muscular Dystrophy Association Awards Human Trial Grant for ALS Research
Massachusetts General Hospital has received a $750,000 human clinical trial grant to explore the use of positron emission tomography imaging of inflammation to serve as a biomarker for amyotrophic lateral sclerosis diagnosis and clinical trials.
Study Finds a 47% Increased Risk of COPD Hospitalization Among RA Patients
Previous studies have revealed a potential connection between chronic inflammatory conditions and the predisposition of chronic obstructive pulmonary disease (COPD), and a new study has found that patients with rheumatoid arthritis (RA) are associated with a greater risk of COPD hospitalization compared to the general population.
FDA Grants Priority Review for Lilly's Verzenio for Metastatic Breast Cancer
The FDA has granted Priority Review designation for Eli Lilly and Company’s New Drug Application (NDA) for Verzenio (abemaciclib), a cyclindependent kinase 4 and 6 inhibitor for metastatic breast cancer. The decision was based on the MONARCH 3 study, which examined abemaciclib as an initial endocrine-based therapy.
ARROW Trial: Multiple Myeloma Patients Have Longer PFS With Kyprolis Once-Weekly Regimen
Results of the Phase 3 ARROW trial revealed that patiehts with refractory multiple myeloma can live up to 3.6 months longer, without their disease worsening, when Kyprolis (carfilzomib) is administered once-weekly at the 70 mg/m2 dose with dexamethasone rather than Kyprolis administered twice-weekly at the 27 mg/m2 dose with dexamethasone, according to Amgen.
Prochlorperzine Is More Effective for Treating Migraines in the ED Than Commonly Used Drugs
Hydromorphone is commonly used in hospital emergency rooms to treat patients with migraines; however, the drug is less effective than the drug prochlorperazine used with diphenhydramine, according to research.
Study Finds Significant Response of Nivolumab-Refractory Lung Cancer to Salvage Chemotherapy
Physicians should be cautious when treating patients with lung cancer after progression on nivolumab because nivolumab-refractory lung cancer could have a significant response to salvage chemotherapy, according to a new study.
Childhood Cancer Survivors Face Job Lock to Keep Insurance Coverage
Many of survivors of childhood cancer who are now within the prime age for labor force participation are reluctant to make changes in their employment because of access to health insurance, and therefore, job lock is common among this population.
Expert Recommendations for Pegfilgrastim in Chemotherapy-Induced Febrile Neutropenia
Researchers developed additional guidance for using granulocyte colony-stimulating factors to optimize pegfilgrastim use in clinical practices for patients at risk of chemotherapy-induced febrile neutropenia.
Study Uses Crowdsourcing Platform for Patient Perspective on Back Pain Research
When patients are directly involved in research, the results better reflect a patient's perspective and clinicians can make more informed decisions. Researchers recently found that crowdsourcing platforms are effective in efficiently reaching groups of individuals to receive input on prevalent conditions, including back pain.